Clearline Capital’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-196,583
| Closed | -$429K | – | 148 |
|
|
2024
Q1 | $429K | Hold |
196,583
| – | – | 0.02% | 112 |
|
|
2023
Q4 | $305K | Hold |
196,583
| – | – | 0.02% | 93 |
|
|
2023
Q3 | $254K | Hold |
196,583
| – | – | 0.02% | 119 |
|
|
2023
Q2 | $338K | Hold |
196,583
| – | – | 0.02% | 106 |
|
|
2023
Q1 | $297K | Hold |
196,583
| – | – | 0.04% | 96 |
|
|
2022
Q4 | $315K | Hold |
196,583
| – | – | 0.06% | 108 |
|
|
2022
Q3 | $285K | Hold |
196,583
| – | – | 0.03% | 125 |
|
|
2022
Q2 | $360K | Buy |
196,583
+5,983
| +3% | +$11K | 0.05% | 116 |
|
|
2022
Q1 | $509K | Buy |
190,600
+45,600
| +31% | +$122K | 0.06% | 100 |
|
|
2021
Q4 | $628K | Buy |
+145,000
| New | +$628K | 0.07% | 104 |
|